RUNX2 and cancer: The positive rate of Vimentin, VE-cadherin, and Galectin-3 expression in the presence of Runx2 was higher than in cancer cells that did not express Runx2, while the positive rate of E-cadherin in Runx2-positive cells was lower than in the Runx2-negative group.